| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/02/2005 | EP1510821A1 Diagnosis and treatment of mycobacterial infections |
| 03/02/2005 | EP1510579A2 Use of heregulin as an epithelial cell growth factor |
| 03/02/2005 | EP1510526A1 Multimeric leptin receptor |
| 03/02/2005 | EP1510524A2 Compounds and peptides that bind to the erythropoietin receptor |
| 03/02/2005 | EP1510224A1 In vivo gene transfer methods for wound healing |
| 03/02/2005 | EP1510220A1 Therapeutic inhibitor of vascular smooth muscle cells |
| 03/02/2005 | EP1510206A1 Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs |
| 03/02/2005 | EP1509773A1 Diagnostics and therapeutics for diseases associated with chemokine receptor 11 (ccr11) |
| 03/02/2005 | EP1509772A2 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 03/02/2005 | EP1509769A2 Method of screening groups of radioactive molecules and applications thereof |
| 03/02/2005 | EP1509768A2 Methods for cohort selection and longevity studies |
| 03/02/2005 | EP1509767A1 Detection of autoantibodies to cytokeratin 18 protein in patients with bronchial asthma and chronic rhinitis, and its applications including a kit for diagnosing bronchial asthma and chronic rhinitis comprising mammalian cytokeratin 18 protein |
| 03/02/2005 | EP1509621A1 Treatment with cytokines for alzheimer's disease |
| 03/02/2005 | EP1509618A2 Autoimmune conditions and nadph oxidase defects |
| 03/02/2005 | EP1509617A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 03/02/2005 | EP1509614A1 Map-kinase inhibitors as regulators of tumor-associated antigen expression |
| 03/02/2005 | EP1509612A2 Transcellular drug delivery system |
| 03/02/2005 | EP1509610A1 Transgenic plants with controlled distribution of a trait to progeny |
| 03/02/2005 | EP1509609A1 Protein hydrolysate rich in tripeptides |
| 03/02/2005 | EP1509606A1 Allergen from mugwort pollen |
| 03/02/2005 | EP1509605A2 Production of recombinant fragments of muscle acetylcholine receptor and their use for ex vivo immunoadsorption of anti-ach receptor antibodies from myasthenic patients |
| 03/02/2005 | EP1509604A2 Molecular targeting of the igf-1 receptor |
| 03/02/2005 | EP1509598A2 Induction of insulin expression |
| 03/02/2005 | EP1509546A1 Collagen and method for producing same |
| 03/02/2005 | EP1509541A2 Novel recombinant anticoagulant proteins |
| 03/02/2005 | EP1509540A2 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
| 03/02/2005 | EP1509253A1 Chimeric cd154 |
| 03/02/2005 | EP1509250A1 Methods compositions and articles of manufacture for modulating bone growth |
| 03/02/2005 | EP1509247A1 Use of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating dieseases |
| 03/02/2005 | EP1509243A1 Topical drug delivery using phosphatidylcholine |
| 03/02/2005 | EP1509242A1 Treatment of hepatitis c in the asian population with subcutaneous interferonbeta |
| 03/02/2005 | EP1509241A1 Novel uses of cephaibols |
| 03/02/2005 | EP1509240A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 03/02/2005 | EP1509239A2 Composition and method for reducing post-prandial blood glucose |
| 03/02/2005 | EP1509236A2 Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions |
| 03/02/2005 | EP1509225A1 Method for the use of pyranoindole derivatives to treat infection with hepatitis c virus |
| 03/02/2005 | EP1509209A1 Compositions and method for transmucosal drug delivery and cryoprotection |
| 03/02/2005 | EP1509206A1 A hemostatic composition |
| 03/02/2005 | EP1509087A2 Treatment for diabetes |
| 03/02/2005 | EP1435998A4 Method for treating hepatitis c virus infection in treatment failure patients |
| 03/02/2005 | EP1421115B1 Soluble t cell receptor |
| 03/02/2005 | EP1342084B1 Assay for anti-viral agent |
| 03/02/2005 | EP1317543B1 Parietaria judaica ns-ltp antigen variants, uses thereof and compositions comprising them |
| 03/02/2005 | EP1198475B1 Highly purified cytokine activating factor and methods of use |
| 03/02/2005 | EP1141294B1 Method of enhancing the biological activity of ligands |
| 03/02/2005 | EP1140240B1 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 03/02/2005 | EP1137764B1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase |
| 03/02/2005 | EP1135105B1 Use of a neurologic agent for the manufacture of a medicament for the treatment of a central nervous system disorder |
| 03/02/2005 | EP1131338B1 Method for the production of purified invasin protein and use thereof |
| 03/02/2005 | EP1034207B1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES |
| 03/02/2005 | EP1014947B1 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein |
| 03/02/2005 | EP0983079B1 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
| 03/02/2005 | EP0979244B1 Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same |
| 03/02/2005 | EP0977881B1 Expression of a modified foamy virus envelope protein |
| 03/02/2005 | EP0959896A4 Human thyrotropin receptor compositions and use thereof |
| 03/02/2005 | EP0910397B1 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 03/02/2005 | EP0907731B1 Metabotropic gaba(b) receptors, receptor-specific ligands and their uses |
| 03/02/2005 | EP0799311B1 Human chemokine beta-9 |
| 03/02/2005 | EP0797591B1 A novel chemokine expressed in inflamed adenoid, its production and uses |
| 03/02/2005 | EP0682708B9 Antiviral composition of viral protein trans-dominant variants |
| 03/02/2005 | CN1589330A Stem cells of the islets of langerhans and their use in treating diabetes |
| 03/02/2005 | CN1589280A Treatment of micro-organism infection |
| 03/02/2005 | CN1589279A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/02/2005 | CN1589257A N-methyl-homocysteines and their use as well as process for their production |
| 03/02/2005 | CN1589152A Novel human beta 2 integrin alpha subunit |
| 03/02/2005 | CN1589151A Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/02/2005 | CN1589150A Method for obtaining estrogens from mare's urine |
| 03/02/2005 | CN1589108A Oilseed processing |
| 03/02/2005 | CN1587395A Method for producing super oxide mutase complex enzyne at large scale using grain seed |
| 03/02/2005 | CN1587384A Antibiotic peptide gene converted viscons bacillus engineering bacterium and its preparing method and use |
| 03/02/2005 | CN1586621A Injected gel type bone repairing biological active material and its preparing method |
| 03/02/2005 | CN1586620A Poly gelatin peptide injection and its preparing method |
| 03/02/2005 | CN1586502A Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use |
| 03/02/2005 | CN1191371C Process for preparing easy body absorption protein iron and health food produced therefrom |
| 03/02/2005 | CN1191363C Beta-lactamase/amino-glucosidic passive enzyme interfused gene, its expresed products and composition thereof and use |
| 03/02/2005 | CN1191362C Streptococcus antigens |
| 03/02/2005 | CN1191360C Modified clotting factor VIII |
| 03/02/2005 | CN1191357C Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 03/02/2005 | CN1191276C Humanized antibodies and method for forming same |
| 03/02/2005 | CN1191273C Long lasting insulinotropic peptides |
| 03/02/2005 | CN1191272C Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP) |
| 03/02/2005 | CN1191271C Thymic peptide fusion protein as one new interferon and its prepn. |
| 03/02/2005 | CN1191270C Cellulose binding domain |
| 03/02/2005 | CN1191269C Pseudomycin natural product |
| 03/02/2005 | CN1191091C Novel preventives/remedies for immunopathy |
| 03/02/2005 | CN1191088C Application of VMIP derivatives in medicine for treating AIDS and inflammation pathology |
| 03/01/2005 | US6861558 Alzheimer's disease |
| 03/01/2005 | US6861539 For inhibiting human immunodeficiency virus protease |
| 03/01/2005 | US6861511 Detection and quantification of neu related proteins in the biological fluids of humans |
| 03/01/2005 | US6861509 Antibodies to Ret and RetL3 |
| 03/01/2005 | US6861506 Compositions and methods for the treatment and diagnosis of breast cancer |
| 03/01/2005 | US6861504 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor |
| 03/01/2005 | US6861441 (4(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo(f)isoindol-2-yl) phenyl)acetic acid |
| 03/01/2005 | US6861409 Compounds for use in the dtreatment of growth metabolic disorders |
| 03/01/2005 | US6861408 Therapeutic anti-melanoma compounds |
| 03/01/2005 | US6861407 Methods of therapy with thrombin derived peptides |
| 03/01/2005 | US6861406 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor |
| 03/01/2005 | US6861405 Administering to an animal a voltage-gated potassium channel Kv1.3 inhibiting amount of a Kv1.3 inhibitor to induce weight loss, decrease body fat, increase insulin sensitivity, decrease food intake and control appetite |
| 03/01/2005 | US6861404 Therapies for chronic renal failure |
| 03/01/2005 | US6861399 Cleaning compositions containing human serine protease T |